Guardian Asset Advisors’s Pfizer PFE Stock Holding History

Guardian Asset Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Sell	11,111 -482	-4%	-$12.6K	0.12%	110
2026 Q1	$326K	Buy	11,593 +1,261	+12%	+$33.6K	0.19%	81
2025 Q4	$257K	Sell	10,332 -492	-5%	-$12.4K	0.13%	95
2025 Q3	$276K	Sell	10,824 -1,900	-15%	-$46.9K	0.15%	90
2025 Q2	$308K	Buy	12,724 +281	+2%	+$6.55K	0.18%	89
2025 Q1	$315K	Sell	12,443 -303	-2%	-$7.93K	0.21%	82
2024 Q4	$338K	Sell	12,746 -462	-3%	-$12.5K	0.22%	78
2024 Q3	$382K	Buy	13,208 +845	+7%	+$24.6K	0.26%	72
2024 Q2	$346K	Buy	+12,363	New	+$340K	0.25%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Guardian Asset Advisors's PFE Position: Q2 2026 in Review

Guardian Asset Advisors reduced its Pfizer (PFE) stake by 4.2% in Q2 2026, selling an estimated $12.6K and leaving 11,111 shares worth $268K. The position accounts for 0.12% of the portfolio, ranked #110.

Guardian Asset Advisors first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $382K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Guardian Asset Advisors held 11,111 shares of Pfizer worth $268K as of Q2 2026.
Guardian Asset Advisors sold 482 Pfizer shares in Q2 2026, an estimated $12.6K.
Pfizer made up 0.12% of Guardian Asset Advisors's portfolio in Q2 2026, its #110 holding.
Guardian Asset Advisors first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Guardian Asset Advisors's Pfizer position peaked at $382K in Q3 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Guardian Asset Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.